Ethnicity-dependent association of HLA DRB1-DQA1-DQB1 alleles in Brazilian multiple sclerosis patients

Acta Neurologica Scandinavica

Volumn 115, Issue 5, 2007, Pages 306-311

  Alves Leon, S V ^a,b   Papais Alvarenga, R ^b,c   Magalhaes M ^b   Alvarenga, M ^b   Thuler, L C S ^b   Fernandez Y Fernandez O ^d  

^a FEDERAL UNIVERSITY OF THE STATE OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c Lagoa Hospital   (Brazil)

^d HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

Human leukocyte antigen; Multiple sclerosis; Pharmacogenetics

Indexed keywords

HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; IMMUNOMODULATING AGENT; INTERFERON;

AFRICA; ALLELE; ARTICLE; BRAZIL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG RESPONSE; ETHNICITY; GENE AMPLIFICATION; GENE LOCUS; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; POLYMERASE CHAIN REACTION;

AFRICAN CONTINENTAL ANCESTRY GROUP; ANTINEOPLASTIC AGENTS; BRAZIL; DRUG RESISTANCE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC HETEROGENEITY; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; INTERFERONS; MALE; MULTIPLE SCLEROSIS; PHENOTYPE;

EID: 34248158343     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2006.00750.x     Document Type: Article

References (30)

1. Alves-Leon SV, Batista E, Papais-Alvarenga R, Quirico-Santos T. Determination of soluble ICAM-1 and TNFalphaR in the cerebrospinal fluid and serum levels in a population of Brazilian patients with relapsing-remitting multiple sclerosis. Arq Neuropsiquiatr 2001 1 : 18 22.
2. Games and the Transatlantic Multiple Sclerosis Genetic Cooperative. A meta-analysis of whole genome linkage screens in multiple sclerosis. J Neuroimmunol 2003 143 : 39 46.
3. Keneally SJ, Pericak-Vanne MA, Heunes JL. The genetic epidemiology of multiple sclerosis. J Neuroimmunol 2003 143 : 7 12.
4. Brooke G. Pharmacotherapy for multiple sclerosis: current and future prospects. Drug & Market Development 2004 15 : 475 478.
5. Sriram U, Barcellos LF, Villoslada P et al. Pharmacogenomic analysis of interferon receptor polymorphisms in multiple sclerosis. Genes Immun 2003 2 : 147 52.
6. Cree ABC, Al-Sabbagh A, Bennett R, Goodin D. Response to interferon beta 1-a treatment in African American multiple sclerosis patients. Arch Neurol 2005 62 : 1681 3.
7. Fusco C, Andreone V, Coppola G et al. HLA-DRB1*1501 and response to copolymer-1 therapy in relapsing-remitting multiple sclerosis. Neurology 2001 57 : 1976 9.
8. Dyment DA, Ebers GC, Sadovnick AD. Genetics of multiple sclerosis. Lancet Neurol 2004 3 : 104 10.
9. Trachtenberg EA, Keyeux G, Bernal JE, Rhodas MC, Erlich HA. Results of Expedition Humana I. Analysis of HLA class II (DRB1-DQA1-DQB1-DPB1) alleles and DR-DQ haplotypes in nine Ameridians populations from Colombia. Tissue Antigens 1996 48 : 174 181.
10. Trachtenberg EA, Keyeux G, Bernal JE, Noble JA, Erlich HA. Results of Expedition Humana II. Analysis of HLA class II alleles in three African American populations from Colombia using the PCR/SSOP: identification of a novel DQB1*02 (*0203) allele. Tissue Antigens 1996 48 : 192 8.
11. Capistrano de Abreu J. Chapters of Brazil's Colonial History - 1500-1800. New York : Oxford University Press, 1997 236 pp.
12. Ribeiro D. O Povo Brasileiro - A formação e o sentido do Brasil. São Paulo : Companhia das Letras, 1995.
13. Caballero A, Alves-Leon SV, Papais Alvarenga R, Fernandez O, Alonso A. HLA DQB1*0602 confers genetic susceptibility to multiple sclerosis in Afro-Brazilian MS patients. Tissue Antigens 1999 54 : 524 6.
14. Alves-Leon SV. HLA DQB1*0602 confere susceptibilidade genética para esclerose múltipla numa população de pacientes da cidade do Rio de Janeiro. UFRJ : Tese, 1999 : 187 pp.
15. Papais-Alvarenga RM, Alves-Leon SV, Miranda Santos CM et al. South Atlantic project: a Brazilian multiple sclerosis trial. In : Arriagada RC, Nogales-Gaete J, eds. Esclerosis Múltiple - Una Mirada Ibero Pan Americana. Santiago, Chile : Arrynog Ediciones, 2002 35 45.
16. Calegaro D, Lolio CA, Radvany J, Tilbery CP, Mendonça RA, Melo AC. Prevalence of multiple sclerosis in the city of São Paulo, Brazil in 1990. Neuroepidemiology 1992 11 : 11 4.
17. Brodner JG, Marsh SGE, Albert ED et al. Nomenclature for factors of the HLA system. Tissue Antigens 1997 49 : 297 321.
18. Buyse I, Decorte R, Cuppens H et al. Rapid DNA typing of class II HLA antigens using the polymerase chain reaction and reverse dot blot hybridization. Tissue Antigens 1993 41 : 1 14.
19. Coulombier P, Hathhcock L, Smith C, Fagan R. Epi Info 6.0. A Word processing Data base and Statistics Program for Public Health [computer program]. Version 6.04d. Atlanta : Centers for Disease Control & Delaware Division of Public Health, 2001.
20. Kappos L, Achtnichts L, Dahlke F, Kuhle J, Sandbrink R, Lindberg RL. Genomics and proteomics: role in the management of multiple sclerosis. J Neurol 2005 252 (Suppl. 3 III21 7.
21. Evans WE, Relling MV. Moving towards individualized medicine with pharmacogenomics. Nature 2004 429 : 464 8.
22. Kirstein-Grossman I, Beckmann JS, Lancet D, Miller A. Pharmacogenetic development of personalized medicine: multiple sclerosis treatment as a model. Drug News Perspect 2002 15 : 558 67.
23. Fernandez O, Fernandez V, Mayorga C et al. HLA class II and response to interferon-beta in multiple sclerosis. Acta Neurol Scand 2005 112 : 391 4.
24. Bae SC, Fraser P, Liang MH. The epidemiology of systemic lupus. Erythematosus in populations of African ancestry: a critical review of the 'Prevalence Gradient Hypothesis'. Arthritis Rheum 1998 41 : 1 16.
25. Just JJ, King MC, Thomson G, Klitz W. African-American HLA class II allele and haplotype diversity. Tissue Antigens 1996 48 : 636 44.
26. Kelly MA, Jacobs KH, Penny MA et al. An investigation of HLA-encoded genetic susceptibility to multiple sclerosis in subjects of Asian Indian and Afro-Caribbean ethnic origin. Tissue Antigens 1995 45 : 197 202.
27. Nesci S, Talexi N, Andreani M, Manna M, Iliesn A, Lucarelli G. An unusual DRB1*1503 haplotype without DRB1 locus in a black African family. Tissue Antigens 1997 49 : 53 5.
28. Spurkland A, Celius EG, Knustsen I, Beiske A, Thorsby E, Vartdal F. The HLA-DQ (_1*0102, _1*0602) heterodimer may confer susceptibility to multiple sclerosis in the absence of the HLA-DR (_1*01, _1*1501) heterodimer. Tissue Antigens 1997 50 : 15 22.
29. Santos CCC, Quirico-Santos T, Frugulhetti I, Alves-Leon SV. Analysis of HLA DQ, DP, DR alleles associated with multiple sclerosis susceptibility in a population from Rio de Janeiro City. Arq Neuropsiquiatr 2002 60 : 1051.
30. The Multiple Sclerosis Genetics Group, Barcellos LF, Oksenberg JR, Green AJ, Bucher P, Rimmler JB, Schmidt S, Garcia ME, Lincoln RR, Pericak-Vance MA, Haines JL, Hauser SL. Genetic basis for clinical expression in multiple sclerosis. Brain 2002 125 : 150 8.